Our vision is to provide the first credible replacement to metal orthopedic implants with an Intelligent Bone Regeneration Technology: OSSIOfiber is a breakthrough material for surgeons who seek to restore healthy bone with nothing permanent left behind.
Location: United States, Massachusetts, Woburn
Employees: 11-50
Phone: +1 833-781-7373
Total raised: $88.1M
Founded date: 2014
Investors 3
| Date | Name | Website |
| - | OCV Partne... | orchardcap... |
| - | Arc Ventur... | arc-vc.com |
| 22.12.2024 | Questa Cap... | questacapi... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 04.12.2024 | - | $27.6M | - |
| 18.10.2022 | Series C | $38.5M | - |
| 13.03.2019 | - | $22M | - |
Mentions in press and media 23
| Date | Title | Description |
| 13.02.2026 | OSSIO Secures $50 Million Credit Facility To Fund Global Growth | OSSIO has closed an initial $40 million senior credit facility, with an additional $10 million available to support future growth, according to Horizon Technology Finance Corporation and Monroe Capital. The financing is designed to provide ... |
| 12.02.2026 | Ossio Secures $50M Senior Credit Facility | Ossio Inc., a Woburn, MA-based developer of orthopedic fixation technology, secured a $50m senior credit facility. The financing was provided by Horizon Technology Finance Corporation (NASDAQ: HRZN) and Monroe Capital LLC, with an initial $... |
| 17.09.2025 | OSSIOfiber® Revolutionizes Orthopedic Surgery with Bio-Integrative Implants, Leaving Only Natural Bone Behind | Ossio Logo Implants That Turn Into Bone OSSIOfiber® is a strong, bio-integrative non-metal implant for orthopedic surgery. It provides stable fixation and is naturally replaced by bone. Once the material is incorporated and gone, there's no... |
| 04.12.2024 | OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues | - |
| 02.12.2024 | OSSIO Closes $27.6 Million Equity Funding | WOBURN, MA, OSSIO, a fast-growing medical device company focused on evolving orthopedic surgery with bio-integrative fixation technology, recently closed on $27.6 million in equity funding. >> Click here for more funding data on OSSI... |
| 02.12.2024 | Ossio Raises $27.6M in Equity Funding | Ossio, a Woburn, MA-based medical device company, raised $27.6M in equity funding. The round was led by Questa Capital, with participation from existing investors MVM Partners, OCV, Ortho-Vision and Courage Capital. The company intends to u... |
| 19.10.2022 | U.S.A-based Ossio closes Series C at USD 38. 5 million | Woburn, U.S.A-based fast-growing orthopaedic fixation technology company, Ossio, closed its Series C at USD 38.5 million. The company announced the closure on October 17, 2022. MVM Partners, a Boston- and London-based growth equity firm, le... |
| 18.10.2022 | Ossio Closes $38.5M Series C Financing | Ossio, a Caesarea, Israel- and Woburn, MA-based orthopedic fixation technology company, raised $38.5M in Series C funding. The round was led by MVM Partners. Dr. Reeders and his MVM colleague Dr. Kevin Cheng join OSSIO’s board of directors ... |
| 17.10.2022 | Ossio Raises $38.5M Series C to fuel its growth in the orthopedic space | |
| 12.03.2020 | OSSIO Receives FDA 510(k) Clearance for OSSIOfiber® Hammertoe Fixation System | WOBURN, Mass — OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber® Hammertoe Fixation System has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment an... |
Show more